📖
Triggering receptors expressed on myeloid cells (TREM-1) and TREM-2 as predictors of pathological complete response to neoadjuvant therapy in triple-negative breast cancer.
Demir N, Gökmen İ, Garbioğlu DB, Taştekin E, Işık E, Özcan E, Erdoğan B, Topaloğlu S, Köylü B, Kıkılı Cİ, Kemik F, Çiçin İ, Selçukbiricik F, Hacıoğlu MB

Triggering receptors expressed on myeloid cells (TREM-1) and TREM-2 as predictors of pathological complete response to neoadjuvant therapy in triple-negative breast cancer.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Breast Cancer.

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Triggering receptors expressed on myeloid cells (TREM-1) and TREM-2 as predictors of pathological complete response to neoadjuvant therapy in triple-negative breast cancer.
Author / Organization Demir N, Gökmen İ, Garbioğlu DB, Taştekin E, Işık E, Özcan E, Erdoğan B, Topaloğlu S, Köylü B, Kıkılı Cİ, Kemik F, Çiçin İ, Selçukbiricik F, Hacıoğlu MB
Subject & Discipline Breast Cancer
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-6104
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »